CA925083A - Sydnonimine derivatives - Google Patents

Sydnonimine derivatives

Info

Publication number
CA925083A
CA925083A CA996993A CA996993A CA925083A CA 925083 A CA925083 A CA 925083A CA 996993 A CA996993 A CA 996993A CA 996993 A CA996993 A CA 996993A CA 925083 A CA925083 A CA 925083A
Authority
CA
Canada
Prior art keywords
sydnonimine derivatives
sydnonimine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA996993A
Other languages
English (en)
Inventor
Freter Kurt
Zeile Karl
Gotz Manfred
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Manfred Gotz
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manfred Gotz, Boehringer Ingelheim GmbH filed Critical Manfred Gotz
Application granted granted Critical
Publication of CA925083A publication Critical patent/CA925083A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/041,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA996993A 1966-08-09 1967-08-03 Sydnonimine derivatives Expired CA925083A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0088408 1966-08-09

Publications (1)

Publication Number Publication Date
CA925083A true CA925083A (en) 1973-04-24

Family

ID=6984280

Family Applications (1)

Application Number Title Priority Date Filing Date
CA996993A Expired CA925083A (en) 1966-08-09 1967-08-03 Sydnonimine derivatives

Country Status (16)

Country Link
JP (1) JPS537433B1 (fr)
BE (1) BE702448A (fr)
BG (1) BG15571A3 (fr)
CA (1) CA925083A (fr)
CH (1) CH507277A (fr)
DE (1) DE1670127A1 (fr)
DK (1) DK126594B (fr)
ES (1) ES343818A1 (fr)
FI (1) FI49420C (fr)
FR (2) FR1551013A (fr)
GB (1) GB1198283A (fr)
IL (1) IL28432A (fr)
NL (1) NL153195B (fr)
PH (1) PH10178A (fr)
SE (1) SE343304B (fr)
YU (1) YU34691B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930736A1 (de) * 1979-07-28 1981-02-12 Cassella Ag Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3837327A1 (de) * 1988-11-03 1990-05-10 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3921460A1 (de) * 1989-06-30 1991-01-03 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE3921796A1 (de) * 1989-07-03 1991-01-17 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4025604A1 (de) * 1990-08-13 1992-02-20 Cassella Ag 3-dicyclohexylamino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
DE4028679A1 (de) * 1990-09-10 1992-03-19 Cassella Ag Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung
AU3632393A (en) * 1992-03-24 1993-10-21 Cassella Aktiengesellschaft Use of sydnonimines to treat erectile dysfunction
DE4337335A1 (de) * 1993-11-02 1995-05-04 Cassella Ag Verfahren zur Herstellung von Sydnoniminium-hydrogensulfaten

Also Published As

Publication number Publication date
NL6710945A (fr) 1968-02-12
DK126594B (da) 1973-07-30
FI49420C (fi) 1975-06-10
FR1551013A (fr) 1968-12-27
BE702448A (fr) 1968-02-08
SE343304B (sv) 1972-03-06
BG15571A3 (bg) 1976-06-21
IL28432A (en) 1972-01-27
GB1198283A (en) 1970-07-08
FR8428M (fr) 1971-07-08
ES343818A1 (es) 1968-12-01
DE1670127A1 (de) 1970-12-03
NL153195B (nl) 1977-05-16
YU34691B (en) 1979-12-31
FI49420B (fr) 1975-02-28
JPS537433B1 (fr) 1978-03-17
CH507277A (de) 1971-05-15
PH10178A (en) 1976-09-16
YU156567A (en) 1979-07-10

Similar Documents

Publication Publication Date Title
CA925083A (en) Sydnonimine derivatives
CA938303A (en) Aminoacetylene derivatives
AU418344B2 (en) Gonatriene derivatives
AU417855B2 (en) Oxazole derivatives
CA921030A (en) N-acyl sydnonimine derivatives
CA728144A (en) Monoazolyl-thiophene derivatives
AU413355B2 (en) 3-nitro-2-oxo-tetrahydroimidazole derivatives
CA747389A (en) Diazacyclooctane derivatives
CA924708A (en) Homogonane derivatives
CA747362A (en) 21-fluoro-17-methylpregnane derivatives
CA747361A (en) 16-aminomethyl-17-alkyltestosterone derivatives
CA743971A (en) Actinospectacin derivatives
CA743105A (en) Mitosane derivatives
CA739967A (en) Thienobenzothiopyrane derivatives
CA739966A (en) Thiaxanthene derivatives
CA737987A (en) Pentahalophenol derivatives
CA734459A (en) Triazino-pyrimidine derivatives
CA733111A (en) Thiaxanthene derivatives
CA729624A (en) Androstanone derivatives
AU404409B2 (en) Benzotriazolyl-coumarin derivatives
CA727108A (en) Piperazine-organotin derivatives
CA725164A (en) 5-nitrofuran derivatives
AU404889B2 (en) Dibenzocyoloheptene derivatives
CA932734A (en) Phenylaminoethanol derivatives
AU412617B2 (en) Bisphenylalkenylamine derivatives